AGENUS INC Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2025-11-10: Form 10-Q; Exhibit 10.3; Description Form of Convertible Promissory Note by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith..
- 2025-11-10: Form 10-Q; Exhibit 10.2; Description Convertible Promissory Note Purchase Agreement by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith..
- 2025-11-10: Form 10-Q; Exhibit 10.1; Description Promissory Note Agreement by and between and Agenus Inc. and Zydus Pharmaceuticals (USA) Inc., dated October 8,2025. Filed herewith..
- 2025-08-11: Form 10-Q; Exhibit 10.3; Description Securities Purchase Agreement dated June 3, 2025 by and between Agenus Inc. and Zynext Ventures USA LLC. Filed herewith..
| Filed | Form | Exhibit | Description |
|---|
| 2025-11-10 | 10-Q | 10.3 | Form of Convertible Promissory Note by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith. |
|---|
| 2025-11-10 | 10-Q | 10.2 | Convertible Promissory Note Purchase Agreement by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith. |
|---|
| 2025-11-10 | 10-Q | 10.1 | Promissory Note Agreement by and between and Agenus Inc. and Zydus Pharmaceuticals (USA) Inc., dated October 8,2025. Filed herewith. |
|---|
| 2025-08-11 | 10-Q | 10.3 | Securities Purchase Agreement dated June 3, 2025 by and between Agenus Inc. and Zynext Ventures USA LLC. Filed herewith. |
|---|
| 2025-08-11 | 10-Q | 10.2 | License Agreement dated June 3, 2025 by and between Agenus Inc. and Zydus Life Sciences Limited. Filed herewith. |
|---|
| 2025-08-11 | 10-Q | 10.1 | Asset Purchase Agreement dated June 3, 2025 by and among Agenus Inc., Agenus West, LLC and Zydus Pharmaceuticals (USA) Inc. Filed herewith. |
|---|